Ranibizumab according to need: A treatment for age-related macular degeneration

被引:195
作者
Spaide, Richard [1 ]
机构
[1] Vitreous Retina Macula Consultants New York, New York, NY 10022 USA
关键词
D O I
10.1016/j.ajo.2007.02.024
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
引用
收藏
页码:679 / 680
页数:2
相关论文
共 5 条
[1]
Ranibizumab versus verteporfin for neovascular age-related macular degeneration [J].
Brown, David M. ;
Kaiser, Peter K. ;
Michels, Mark ;
Soubrane, Gisele ;
Heier, Jeffrey S. ;
Kim, Robert Y. ;
Sy, Judy P. ;
Schneider, Susan .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1432-1444
[2]
Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration [J].
Ferrara, Napoleone ;
Damico, Lisa ;
Shams, Naveed ;
Lowman, Henry ;
Kim, Robert .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (08) :859-870
[3]
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (lucentis) for neovascular age-related macular degeneration [J].
Fung, Anne E. ;
Lalwani, Geeta A. ;
Rosenfeld, Philip J. ;
Dubovy, Sander R. ;
Michels, Stephan ;
Feuer, William J. ;
Puliafito, Carmen A. ;
Davis, Janet L. ;
Flynn, Harry W., Jr. ;
Esquiabro, Maria .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (04) :566-583
[4]
Ranibizumab for neovascular age-related macular degeneration [J].
Rosenfeld, Philip J. ;
Brown, David M. ;
Heier, Jeffrey S. ;
Boyer, David S. ;
Kaiser, Peter K. ;
Chung, Carol Y. ;
Kim, Robert Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1419-1431
[5]
WU KB, SOURCES INCOME OLDER